Back to results
CompletedPhase 3

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

NCT02006641

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

US338

Phoenix, Arizona, United States

+161 additional locations

View on ClinicalTrials.gov
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil — TrialFind